Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-27

FDA Approved: ARGATROBAN — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved Argatroban under an Original Application (NDA209552) by Eugia US LLC, establishing its use as a direct thrombin inhibitor for patients with heparin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Argatroban (argatroban)

Snippet

ORIG AP for ARGATROBAN (ARGATROBAN)